These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 9177281)
61. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation. Quesnel B; Preudhomme C; Lepelley P; Hetuin D; Vanrumbeke M; Bauters F; Velu T; Fenaux P Br J Haematol; 1996 Nov; 95(2):291-8. PubMed ID: 8904884 [TBL] [Abstract][Full Text] [Related]
62. Retroviral introduction of the p16 gene into murine cell lines to elicit marked antiproliferative effects. Ikeda H; Yoshida J; Yamada H; Yoshimatsu T; Ikenaka K Jpn J Cancer Res; 1997 Aug; 88(8):712-7. PubMed ID: 9330601 [TBL] [Abstract][Full Text] [Related]
63. Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control. Takahashi A; Ohtani N; Hara E Cell Div; 2007 Mar; 2():10. PubMed ID: 17343761 [TBL] [Abstract][Full Text] [Related]
64. Retroviral transfer of the p16INK4a cDNA inhibits C6 glioma formation in Wistar rats. Strauss BE; Fontes RB; Lotfi CF; Skorupa A; Bartol I; Cipolla-Neto J; Costanzi-Strauss E Cancer Cell Int; 2002 Apr; 2(1):2. PubMed ID: 11983028 [TBL] [Abstract][Full Text] [Related]
65. Abnormalities of the P16INK4A gene in thyroid cancer cell lines. Ivan M; Wynford-Thomas D; Jones CJ Eur J Cancer; 1996 Dec; 32A(13):2369-70. PubMed ID: 9038627 [No Abstract] [Full Text] [Related]
66. Identification of a region within SEL1L protein required for tumour growth inhibition. Cattaneo M; Canton C; Albertini A; Biunno I Gene; 2004 Feb; 326():149-56. PubMed ID: 14729273 [TBL] [Abstract][Full Text] [Related]
67. Re-thinking cell cycle regulators: the cross-talk with metabolism. Fajas L Front Oncol; 2013; 3():4. PubMed ID: 23355973 [TBL] [Abstract][Full Text] [Related]
68. Polymorphism of p16INK4a gene and rare mutation of p15INK4b gene exon2 in primary hepatocarcinoma. Qin Y; Li B; Tan YS; Sun ZL; Zuo FQ; Sun ZF World J Gastroenterol; 2000 Jun; 6(3):411-414. PubMed ID: 11819612 [No Abstract] [Full Text] [Related]
69. Molecular control of the cell cycle in cancer: biological and clinical aspects. Møller MB Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137 [TBL] [Abstract][Full Text] [Related]
70. p16INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression. Larsen CJ Oncogene; 1996 May; 12(10):2041-4. PubMed ID: 8668328 [No Abstract] [Full Text] [Related]
71. Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators. Suzuki-Takahashi I; Higashi H; Yoshida E; Nishimura S; Kitagawa M Biochem Biophys Res Commun; 1997 May; 234(2):386-92. PubMed ID: 9177281 [TBL] [Abstract][Full Text] [Related]
72. Cloning and characterization of murine p16INK4a and p15INK4b genes. Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726 [TBL] [Abstract][Full Text] [Related]
73. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Easton J; Wei T; Lahti JM; Kidd VJ Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589 [TBL] [Abstract][Full Text] [Related]
74. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. Alevizopoulos K; Vlach J; Hennecke S; Amati B EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992 [TBL] [Abstract][Full Text] [Related]
75. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines. Costanzi-Strauss E; Strauss BE; Naviaux RK; Haas M Exp Cell Res; 1998 Jan; 238(1):51-62. PubMed ID: 9457056 [TBL] [Abstract][Full Text] [Related]